{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:07:46Z","timestamp":1791497266805,"version":"4.3.4"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:00:00Z","timestamp":1350518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytometry Part B Clinical"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>The diagnosis of AML with monocytic differentiation is limited by the lack of highly sensitive and specific monocytic markers. Immunoglobulin\u2010like transcript 3 (ILT3) is an immune inhibitory receptor expressed by myelomonocytic cells and at high levels by tolerogenic dendritic cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Using flow cytometry, we analyzed the expression of ILT3 in 37 patients with AML and 20 patients with no detectable disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>We showed that ILT3 was expressed in all cases of AML displaying monocytic differentiation (FAB M4\/M5; <jats:italic>N<\/jats:italic> = 18), but not in AML M1\/M2 and M3 (<jats:italic>N<\/jats:italic> = 19; <jats:italic>P<\/jats:italic> &lt; 0.0001). Co\u2010expression of ILT3 and immature cell markers, such as CD34 and CD117, was observed in monoblastic leukemia. ILT3 expression was preserved after treatment in M4\/M5 patients with refractory or relapsed disease. ILT3 expression was associated with the presence of cytogenetic abnormalities linked to an intermediate prognosis (<jats:italic>P<\/jats:italic> = 0.001). Rare CD45dimCD34+CD117+ILT3+ cells were identified in noninvolved bone marrow, suggesting that ILT3 expression is acquired at an early stage by normal myelomonocytic precursors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>ILT3 is a highly sensitive and specific marker which distinguishes AML with monocytic differentiation from other types of AML. Testing of ILT3 expression should be incorporated into the initial diagnostic work\u2010up and monitoring of patients with AML. \u00a9 2012 International Clinical Cytometry Society<\/jats:p><\/jats:sec>","DOI":"10.1002\/cyto.b.21050","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T17:47:06Z","timestamp":1349113626000},"page":"21-29","source":"Crossref","is-referenced-by-count":63,"title":["Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation"],"prefix":"10.1002","volume":"84B","author":[{"given":"Hanna","family":"Dobrowolska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamraan Z.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geo","family":"Serban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Suciu\u2010Foca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Alobeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana I.","family":"Colovai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,18]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"110","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"Arber DA","year":"2008"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.47"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.11.001"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69780-8"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.2554"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074306"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-1099-0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-187724"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-7920-6_3"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254441"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPZ46PMMAWJROT"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1309\/NALM-440G-4GFY-XPVE"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e31815db477"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2010.01533.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.5858\/2007-131-748-TVOCEI","article-title":"The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases","volume":"131","author":"Dunphy CH","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-679X(04)75028-1"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1309\/BH588HVG6UHN2RF2"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.10.1743"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01162.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4742"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.290.5489.84"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03097.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.221028"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.035683"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni760"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804048"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001732"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.10.007"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20164"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.005421"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.6.797"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2007.05.006"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2708"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.0371"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1746"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178331"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1117729"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.7432"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0054"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcyto.b.21050","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.21050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:18:11Z","timestamp":1700669891000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.21050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,18]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1002\/cyto.b.21050"],"URL":"https:\/\/doi.org\/10.1002\/cyto.b.21050","archive":["Portico"],"relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"value":"1552-4949","type":"print"},{"value":"1552-4957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,18]]}}}